Cargando…
Circulating tumor cells in whole process management of gastrointestinal stromal tumor in a real-life setting
BACKGROUND/AIM: Liquid biopsy is changing the diagnosis and treatment strategies of various neoplasms. However, the circulating tumor cells (CTCs) of gastrointestinal stromal tumor (GIST) patients with different disease process are not clear. To better understand the dynamic change of CTCs in GIST p...
Autores principales: | Zhang, Qiang, Xu, Kangjing, Chen, Ming, Miao, Yongchang, Wang, Nuofan, Xu, Zekuan, Xu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392290/ https://www.ncbi.nlm.nih.gov/pubmed/32386192 http://dx.doi.org/10.4103/sjg.SJG_24_20 |
Ejemplares similares
-
HIF-1α regulates cellular metabolism, and Imatinib resistance by targeting phosphogluconate dehydrogenase in gastrointestinal stromal tumors
por: Xu, Kangjing, et al.
Publicado: (2020) -
HMGA1 Regulates the Stem Cell-Like Properties of Circulating Tumor Cells from GIST Patients via Wnt/β-Catenin Pathway
por: Chen, Ming, et al.
Publicado: (2020) -
Practical Role of Mutation Analysis for Imatinib Treatment in Patients With Advanced Gastrointestinal Stromal Tumors: A Meta-Analysis
por: Zhi, Xiaofei, et al.
Publicado: (2013) -
The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells
por: Xing, Ya-Nan, et al.
Publicado: (2016) -
Ghrelin and gastrointestinal stromal tumors
por: Zhu, Chang-Zhen, et al.
Publicado: (2017)